SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
47 hedge funds and large institutions have $160M invested in SQZ Biotechnologies Company in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 2 closing their positions.
550% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 7
31% more funds holding
Funds holding: 36 → 47 (+11)
32% less capital invested
Capital invested by funds: $234M → $160M (-$74.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIG
American International Group
New York
|
+$51.1M |
| 2 |
LM
Luminus Management
Houston,
Texas
|
+$9.55M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.98M |
| 4 |
6CM
683 Capital Management
New York
|
+$2.47M |
| 5 |
Walleye Capital
New York
|
+$1.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$505K |
| 2 |
CCM
CAAS Capital Management
New York
|
-$369K |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$212K |
| 4 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$63.5K |
| 5 |
Morgan Stanley
New York
|
-$35.1K |
SQZ Hedge Fund Activity: Q1 2021 in Review
47 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q1 2021, worth a combined $160M — down 32% from $234M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new SQZ positions and 2 closed out — a net gain of 11 holders — while 21 added to existing stakes and 7 trimmed.
The largest buyer was American International Group, adding an estimated $51.1M. The largest seller was HRT Financial, exiting entirely with an estimated $505K sold.
- 47 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q1 2021, up from 36 in Q4 2020.
- Funds reported $160M of SQZ Biotechnologies Company stock for Q1 2021, down 32% quarter-over-quarter.
- 13 funds opened new SQZ Biotechnologies Company positions in Q1 2021 and 2 closed out, a net change of +11 holders.
- The largest SQZ Biotechnologies Company buyer in Q1 2021 was American International Group, an estimated $51.1M added.
- The largest SQZ Biotechnologies Company seller in Q1 2021 was HRT Financial, an estimated $505K sold.
Based on aggregated 13F filings for Q1 2021.